Eupraxia Pharmaceuticals Inc
(EPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | ||
| Net Income | -3,956 | -18,991 |
| Depreciation Amortization | 38 | 148 |
| Accounts receivable | 2 | N/A |
| Other Working Capital | -1,419 | 1,515 |
| Other Operating Activity | 769 | 2,933 |
| Operating Cash Flow | $-4,567 | $-14,395 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -8 | -235 |
| Other Investing Activity | 0 | 10,069 |
| Investing Cash Flow | $-8 | $9,834 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 230 | N/A |
| Other Financing Activity | -36 | 10,801 |
| Financing Cash Flow | $195 | $10,801 |
| Exchange Rate Effect | 45 | -507 |
| Beginning Cash Position | 18,263 | 12,531 |
| End Cash Position | 13,928 | 18,263 |
| Net Cash Flow | $-4,336 | $5,733 |
| Free Cash Flow | ||
| Operating Cash Flow | -4,567 | -14,395 |
| Capital Expenditure | -8 | N/A |
| Free Cash Flow | -4,575 | -14,395 |